吉尔伯特综合征再次出现
Libor Vítek1, Claudio Tiribelli2
11st Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Journal of hepatology
|June 30, 2023
概括
吉尔伯特综合征是一种轻微升高的非结合性白素,可能会保护心血管疾病,癌症和神经退行性疾病,这是由于白素的抗氧化特性.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 生物化学 生物化学
- 内部医学 内部医学
背景情况:
- 吉尔伯特综合征,或良性高 bilirubinemia,是一个常见的生理条件.
- 具有轻度的非结合性高胆氨酸血症的特征,没有肝脏疾病或血液溶解.
- 在历史上被视为一种异常,最近的研究表明潜在的好处.
研究的目的:
- 审查目前关于吉尔伯特综合征的知识.
- 为了探索轻度高白血病的保护作用.
- 讨论最近发现的临床意义.
主要方法:
- 关于吉尔伯特综合征和胆红素的研究文献综述.
- 对 bilirubin 的抗氧化和信号通路的研究分析.
- 综合关于防治疾病的证据.
主要成果:
- 比利鲁表现出强大的抗氧化作用.
- 比利鲁会影响多个细胞内信号通路.
- 有证据表明,它可以预防心血管,癌症,自身免疫和神经退行性疾病.
结论:
- 吉尔伯特综合征可能会给健康带来好处.
- 轻度的高白血可能会对"文明疾病"有保护作用.
- 提出了对吉尔伯特综合征作为潜在的保护性疾病的新视角.
相关概念视频
Gastritis-II: Pathophysiology
380
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
380
Barrett Esophagus-II: Clinical Manifestations and Management
214
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
214
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
362
Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
362
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
195
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
195
Irritable Bowel Syndrome I: Introduction
322
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
322
Myasthenia Gravis: Overview and Treatment
1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K


